Lysozyme Amyloid Oligomers and Fibrils Induce Cellular Death via Different Apoptotic/Necrotic Pathways

Journal of Molecular Biology

Volumn 365, Issue 5, 2007, Pages 1337-1349

  Gharibyan, Anna L ^a   Zamotin, Vladimir ^a   Yanamandra, Kiran ^a   Moskaleva, Olesya S ^a,b   Margulis, Boris A ^b   Kostanyan, Irina A ^c   Morozova Roche, Ludmilla A ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b INSTITUTE OF CYTOLOGY   (Russian Federation)

^c SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

amyloid cytotoxicity; apoptosis; fibrils; necrosis; oligomers

Indexed keywords

AMYLOID; CASPASE; FLUORESCENT DYE; LACTATE DEHYDROGENASE; LIPOCORTIN 5; LYSOZYME; OLIGOMER; PHOSPHATIDYLSERINE; PROPIDIUM IODIDE;

AMYLOIDOSIS; APOPTOSIS; ARTICLE; ATOMIC FORCE MICROSCOPY; BETA SHEET; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE DAMAGE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM;

EID: 33846023647     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.10.101     Document Type: Article

References (60)

1. Dobson C.M. Protein misfolding, evolution and disease. Trends Biochem. Sci. 24 (1999) 329-332
2. Makin O.S., and Serpell L.C. Examining the structure of the mature amyloid fibril. Biochem. Soc. Trans. 30 (2002) 521-525
3. Stefani M., and Dobson C.M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J. Mol. Med. 81 (2003) 678-699
4. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416 (2002) 507-511
5. Morozova-Roche L.A., Zamotin V., Malisauskas M., Ohman A., Chertkova R., Lavrikova M.A., et al. Fibrillation of carrier protein albebetin and its biologically active constructs. Multiple oligomeric intermediates and pathways. Biochemistry 43 (2004) 9610-9619
6. Pedersen J.S., Dikov D., Flink J.L., Hjuler H.A., Christiansen G., and Otzen D.E. The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting. J. Mol. Biol. 355 (2006) 501-523
7. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
8. Gong Y., Chang L., Viola K.L., Lacor P.N., Lambert M.P., Finch C.E., et al. Alzheimer's disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl Acad. Sci. USA 100 (2003) 10417-10422
9. Malisauskas M., Ostman J., Darinskas A., Zamotin V., Liutkevicius E., Lundgren E., and Morozova-Roche L.A. Does the cytotoxic effect of transient amyloid oligomers from common equine lysozyme in vitro imply innate amyloid toxicity?. J. Biol. Chem. 280 (2005) 6269-6275
10. Malisauskas M., Darinskas A., Zamotin V.V., Gharibyan A., Kostanyan I.A., and Morozova-Roche L.A. Intermediate amyloid oligomers of lysozyme: is their cytotoxicity a particular case or general rule for amyloid?. Biochemistry (Mosc.) 71 (2006) 505-512
11. Zamotin V., Gharibyan A., Gibanova N.V., Lavrikova M.A., Dolgikh D.A., Kirpichnikov M.P., et al. Cytotoxicity of albebetin oligomers depends on cross-β-sheet formation. FEBS Letters 580 (2006) 2451-2457
12. Reixach N., Deechongkit S., Jiang X., Kelly J.W., and Buxbaum J.N. Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc. Natl Acad. Sci. USA 101 (2004) 2817-2822
13. Andersson K., Olofsson A., Nielsen E.H., Svehag S.E., and Lundgren E. Only amyloidogenic intermediates of transthyretin induce apoptosis. Biochem. Biophys. Res. Commun. 294 (2002) 309-314
14. Volles M.J., Lee S.J., Rochet J.C., Shtilerman M.D., Ding T.T., Kessler J.C., and Lansbury Jr. P.T. Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40 (2001) 7812-7819
15. Ding T.T., Lee S.J., Rochet J.C., and Lansbury Jr. P.T. Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes. Biochemistry 41 (2002) 10209-10217
16. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
17. Wogulis M., Wright S., Cunningham D., Chilcote T., Powell K., and Rydel R.E. Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J. Neurosci. 25 (2005) 1071-1080
18. Anderluh G., Gutierrez-Aguirre I., Rabzelj S., Ceru S., Kopitar-Jerala N., Macek P., et al. Interaction of human stefin B in the prefibrillar oligomeric form with membranes. Correlation with cellular toxicity. FEBS J. 272 (2005) 3042-3051
19. Chromy B.A., Nowak R.J., Lambert M.P., Viola K.L., Chang L., Velasco P.T., et al. Self-assembly of Aβ(1-42) into globular neurotoxins. Biochemistry 42 (2003) 12749-12760
20. Bhatia R., Lin H., and Lal R. Fresh and globular amyloid β protein (1-42) induces rapid cellular degeneration: evidence for AβP channel-mediated cellular toxicity. FASEB J. 14 (2000) 1233-1243
21. Sirangelo I., Malmo C., Iannuzzi C., Mezzogiorno A., Bianco M.R., Papa M., and Irace G. Fibrillogenesis and cytotoxic activity of the amyloid-forming apomyoglobin mutant W7FW14F. J. Biol. Chem. 279 (2004) 13183-13189
22. Howlett D.R., Jennings K.H., Lee D.C., Clark M.S., Brown F., Wetzel R., et al. Aggregation state and neurotoxic properties of Alzheimer β-amyloid peptide. Neurodegeneration 4 (1995) 23-32
23. Pike C.J., Walencewicz A.J., Glabe C.G., and Cotman C.W. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563 (1991) 311-314
24. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., and Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13 (1993) 1676-1687
25. Roher A.E., Ball M.J., Bhave S.V., and Wakade A.R. β-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons. Biochem. Biophys. Res. Commun. 174 (1991) 572-579
26. Kuroda Y., and Kawahara M. Aggregation of amyloid β-protein and its neurotoxicity: enhancement by aluminum and other metals. Tohoku J. ExpT. Med. 174 (1994) 263-268
27. Lorenzo A., and Yankner B.A. β-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl Acad. Sci. USA 91 (1994) 12243-12247
28. Forloni G., Bugiani O., Tagliavini F., and Salmona M. Apoptosis-mediated neurotoxicity induced by β-amyloid and PrP fragments. Mol. Chem. Neuropathol. 28 (1996) 163-171
29. Forloni G. Neurotoxicity of β-amyloid and prion peptides. Curr. Opin. Neurol. 9 (1996) 492-500
30. Weldon D.T., Rogers S.D., Ghilardi J.R., Finke M.P., Cleary J.P., O'Hare E., et al. Fibrillar β-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J. Neurosci. 18 (1998) 2161-2173
31. Petkova A.T., Leapman R.D., Guo Z., Yau W.M., Mattson M.P., and Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307 (2005) 262-265
32. Novitskaya V., Bocharova O.V., Bronstein I., and Baskakov I.V. Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons. J. Biol. Chem. 281 (2006) 13828-13836
33. Bamberger M.E., Harris M.E., McDonald D.R., Husemann J., and Landreth G.E. A cell surface receptor complex for fibrillar β-amyloid mediates microglial activation. J. Neurosci. 23 (2003) 2665-2674
34. Sousa M.M., Du Yan S., Fernandes R., Guimaraes A., Stern D., and Saraiva M.J. Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J. Neurosci. 21 (2001) 7576-7586
35. Saito T., Kijima H., Kiuchi Y., Isobe Y., and Fukushima K. β-amyloid induces caspase-dependent early neurotoxic change in PC12 cells: correlation with H2O2 neurotoxicity. Neurosci. Letters 305 (2001) 61-64
36. Wei W., Wang X., and Kusiak J.W. Signaling events in amyloid β-peptide-induced neuronal death and insulin-like growth factor I protection. J. Biol. Chem. 277 (2002) 17649-17656
37. Bucciantini M., Calloni G., Chiti F., Formigli L., Nosi D., Dobson C.M., and Stefani M. Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J. Biol. Chem. 279 (2004) 31374-31382
38. Broker L.E., Kruyt F.A., and Giaccone G. Cell death independent of caspases: a review. Clin. Cancer Res. 11 (2005) 3155-3162
39. Unal-Cevik I., Kilinc M., Can A., Gursoy-Ozdemir Y., and Dalkara T. Apoptotic and necrotic death mechanisms are concomitantly activated in the same cell after cerebral ischemia. Stroke 35 (2004) 2189-2194
40. Chi S., Kitanaka C., Noguchi K., Mochizuki T., Nagashima Y., Shirouzu M., et al. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Oncogene 18 (1999) 2281-2290
41. Krebs M.R., Wilkins D.K., Chung E.W., Pitkeathly M.C., Chamberlain A.K., Zurdo J., et al. Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the β-domain. J. Mol. Biol. 300 (2000) 541-549
42. Fujiwara S., Matsumoto F., and Yonezawa Y. Effects of salt concentration on association of the amyloid protofilaments of hen egg white lysozyme studied by time-resolved neutron scattering. J. Mol. Biol. 331 (2003) 21-28
43. Vernaglia B.A., Huang J., and Clark E.D. Guanidine hydrochloride can induce amyloid fibril formation from hen egg-white lysozyme. Biomacromolecules 5 (2004) 1362-1370
44. Frare E., Polverino De Laureto P., Zurdo J., Dobson C.M., and Fontana A. A highly amyloidogenic region of hen lysozyme. J. Mol. Biol. 340 (2004) 1153-1165
45. Cao A., Hu D., and Lai L. Formation of amyloid fibrils from fully reduced hen egg white lysozyme. Protein Sci. 13 (2004) 319-324
46. Pepys M.B., Hawkins P.N., Booth D.R., Vigushin D.M., Tennent G.A., Soutar A.K., et al. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 362 (1993) 553-557
47. Morozova-Roche L.A., Zurdo J., Spencer A., Noppe W., Receveur V., Archer D.B., et al. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. J. Struct. Biol. 130 (2000) 339-351
48. LeVine III H. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2 (1993) 404-410
49. Harper J.D., Wong S.S., Lieber C.M., and Lansbury Jr. P.T. Assembly of Aβ amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry 38 (1999) 8972-8980
50. Kelly J.W. Mechanisms of amyloidogenesis. Nature Struct. Biol. 7 (2000) 824-826
51. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., and Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148 (1992) 2207-2216
52. Martin S.J., Reutelingsperger C.P., McGahon A.J., Rader J.A., van Schie R.C., LaFace D.M., and Green D.R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Expt. Med. 182 (1995) 1545-1556
53. Leist M., Single B., Castoldi A.F., Kuhnle S., and Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Expt. Med. 185 (1997) 1481-1486
54. Krysko O., De Ridder L., and Cornelissen M. Phosphatidylserine exposure during early primary necrosis (oncosis) in JB6 cells as evidenced by immunogold labeling technique. Apoptosis 9 (2004) 495-500
55. Hirt U.A., and Leist M. Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells. Cell Death Differ. 10 (2003) 1156-11564
56. Leist M., and Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nature Rev. Mol. Cell Biol. 2 (2001) 589-598
57. Jellinger K.A., and Stadelmann C.H. The enigma of cell death in neurodegenerative disorders. J. Neural Transm. 60 (2000) 21-36 (Suppl.)
58. Yamamoto A., Lucas J.J., and Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101 (2000) 57-66
59. Xue L., Fletcher G.C., and Tolkovsky A.M. Mitochondria are selectively eliminated from eukaryotic cells after blockade of caspases during apoptosis. Curr. Biol. 11 (2001) 361-365
60. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., and Ashe K.H. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nature Neurosci. 8 (2005) 79-84